- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Disruptive Mood Dysregulation Disorder in Finland
Total 329 results
-
Merck Sharp & Dohme LLCTerminatedTreatment Resistant DepressionUnited States
-
LivaNovaRecruiting
-
CephalonCompletedBipolar I DepressionUnited States, Bulgaria, Hungary, Romania
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedDepressive Disorder | Depression | Depressive Disorder, MajorColombia, Mexico, United States, Peru, Chile, Argentina
-
COMPASS PathwaysRecruitingTreatment Resistant DepressionUnited States, Spain, Ireland, France, United Kingdom, Canada, Sweden
-
TakedaCompletedDepressive Disorder, MajorTaiwan, Germany, Hong Kong, Poland, Malaysia, Romania, Serbia, Ukraine, Japan, Finland, Latvia, Croatia, India, Korea, Republic of, Philippines, Russian Federation
-
ACADIA Pharmaceuticals Inc.CompletedAdjunctive Treatment of Major Depressive DisorderUnited States
-
Relmada Therapeutics, Inc.CompletedMajor Depressive DisorderUnited States
-
ACADIA Pharmaceuticals Inc.CompletedAdjunctive Treatment of Major Depressive DisorderUnited States, Serbia, Finland, Poland, Russian Federation, Ukraine, United Kingdom, Slovakia, South Africa
-
PfizerCompletedMajor Depressive DisorderCanada, United States, Colombia, Croatia, Estonia, Finland, Poland, France, Slovakia, Chile, Latvia, Lithuania, Romania, South Africa
-
AstraZenecaTerminatedMajor Depressive DisorderUnited States, Estonia, Japan, Finland, India
-
Bristol-Myers SquibbCompletedDepressionItaly, South Africa, United States, Australia, Argentina, Canada, Austria, France, Spain, India, Puerto Rico, United Kingdom
-
Eli Lilly and CompanyCompletedMajor Depressive DisorderUnited States, Germany, Italy, Turkey, Russian Federation, Korea, Republic of, Greece, France, Croatia, Romania, Spain, Argentina, Puerto Rico, Belgium, Mexico, Slovakia
-
Assurex Health Inc.University of MichiganCompletedMajor Depressive Disorder (MDD)United States
-
Axsome Therapeutics, Inc.CompletedDepression | Major Depressive DisorderUnited States
-
ShireCompletedAttention-Deficit/Hyperactivity DisorderUnited States, Canada
-
Repligen CorporationCompletedBipolar I DepressionUnited States
-
H. Lundbeck A/STakedaCompletedDepressive Disorder, MajorUnited States, Bulgaria, Canada, Colombia, Estonia, France, Germany, Hungary, Italy, Korea, Republic of, Latvia, Mexico, Poland, Russian Federation, Serbia, South Africa, Spain, Ukraine, United Kingdom
-
AstraZenecaTargacept Inc.CompletedDepression | Major Depressive DisorderUnited States, India, Puerto Rico
-
Naurex, Inc, an affiliate of Allergan plcCompletedDepressive Disorder, MajorUnited States
-
AstraZenecaTargacept Inc.CompletedDepression | Major Depressive DisorderUnited States, India
-
Forest LaboratoriesCompletedMajor Depressive DisorderUnited States, Canada
-
ShireCompletedAttention-Deficit/Hyperactivity DisorderUnited States
-
ShireCompletedAttention-Deficit/Hyperactivity DisorderUnited States
-
CephalonTerminatedDepressionUnited States, Argentina, Australia, Brazil, Bulgaria, Canada, Croatia, France, Germany, Hungary, Italy, Poland, Serbia, Slovakia, South Africa, Spain, Ukraine
-
Janssen Research & Development, LLCCompletedDepressive Disorder, MajorUnited States, Belgium, Czechia, Ukraine, Poland, Malaysia, Serbia, Bulgaria, Argentina, Lithuania, Slovakia, Russian Federation, Canada, United Kingdom, Latvia
-
TakedaH. Lundbeck A/SCompletedMajor Depressive DisorderUnited States, Mexico, Canada
-
Biohaven Therapeutics Ltd.Enrolling by invitation
-
Eli Lilly and CompanyCompletedDepression | Schizophrenia | Schizoaffective DisorderUnited States
-
Alkermes, Inc.CompletedMajor Depressive DisorderUnited States, Bulgaria
-
PfizerCompletedMajor Depressive DisorderUnited States, Japan
-
GlaxoSmithKlineCompletedDepressive Disorder, Major | Major Depressive Disorder (MDD)United States
-
Intra-Cellular Therapies, Inc.CompletedBipolar DepressionUnited States
-
Clexio Biosciences Ltd.CompletedAdjunctive Treatment of Major Depressive DisorderUnited States, Puerto Rico
-
Otsuka Pharmaceutical Development & Commercialization...CompletedMental Disorders | Depressive Disorder | Depression | Mood Disorders | Depressive Disorder, MajorUnited States, France, Poland, Russian Federation, Romania, Ukraine, Germany, Hungary, Slovakia, Serbia, Canada
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedMenstruation Disturbances | Premenstrual SyndromeUnited States, Canada
-
ShireCompletedMajor Depressive DisorderUnited States
-
Axsome Therapeutics, Inc.CompletedTreatment Resistant Major Depressive DisorderUnited States
-
Pfizer's Upjohn has merged with Mylan to form Viatris...CompletedBipolar Disorder | Depression, BipolarUnited States, Australia, India
-
SunovionCompletedAdult Attention Deficit Hyperactivity DisorderUnited States
-
CephalonCompletedADHD | Attention Deficit/Hyperactivity DisorderUnited States
-
Axsome Therapeutics, Inc.CompletedDepression | Major Depressive Disorder | Treatment Resistant DepressionUnited States
-
GlaxoSmithKlineCompletedDepressive Disorder, Major | Major Depressive Disorder (MDD)United States
-
Eli Lilly and CompanyCompletedTreatment Resistant DepressionUnited States, Argentina, Russian Federation, South Africa, India, Turkey, Puerto Rico, Mexico
-
Intra-Cellular Therapies, Inc.CompletedBipolar DepressionRussian Federation, Ukraine, United States, Bulgaria, Serbia
-
Otsuka Pharmaceutical Development & Commercialization...TerminatedMajor Depressive Disorder (MDD)United States, Spain, Hungary, South Africa, Croatia, France, Poland, India, Canada, Sweden, Malaysia
-
NovartisCompletedMajor Depressive Disorder (MDD)United States
-
TakedaCompletedDepressive Disorder, MajorUnited States
-
Eli Lilly and CompanyCompletedAttention Deficit Hyperactivity DisorderUnited States, Australia, Belgium, Canada, France, Germany, Israel, Italy, Netherlands, Norway, Puerto Rico, South Africa, Sweden, United Kingdom
-
ShireCompletedAttention-Deficit/Hyperactivity DisorderUnited States, Poland, Spain, Canada, Hungary, Belgium, Germany, Italy, Sweden, United Kingdom